Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients

Journal Title: Turkish Journal of Hematology - Year 2017, Vol 34, Issue 1

Abstract

Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients

Authors and Affiliations

Klara Pecankova, Pavel Majek, Jaroslav Cermak, Jan E. Dyr

Keywords

Related Articles

Simultaneous occurrence of Kaposi’s sarcoma and nodular lymphocyte predominant subtype of Hodgkin’s lymphoma in the same lymph node

Many cases have been established with coexisting Kaposi’s sarcoma (KS) and classical Hodgkin’s Lymphoma (C-HL) in the same lymph node. But composite presentation of KS and Nodular Lymphocyte Predominant subtype of Hodgki...

Allogeneic Transplantation In Chronic Myeloid Leukemia And The Effect Of Tyrosine Kinase Inhibitors On Survival, A Quasi-Experimental Study

Objective: Tyrosine kinase inhibitors (TKIs) have changed the indications for allogeneic hematopoietic stem cell transplantation (allo-HSCT) in chronic myeloid leukemia (CML). Therefore, we aimed to evaluate the effect o...

Download PDF file
  • EP ID EP224117
  • DOI 10.4274/tjh.2016.0251
  • Views 117
  • Downloads 0

How To Cite

Klara Pecankova, Pavel Majek, Jaroslav Cermak, Jan E. Dyr (2017). Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients. Turkish Journal of Hematology, 34(1), 111-113. https://www.europub.co.uk/articles/-A-224117